Press & News
LA JOLLA—Immunotherapy, which uses the body’s own immune system to fight cancer, is an effective treatment option, yet many patients do not respond to it. Thus, cancer researchers are seeking …
LA JOLLA—Even for killer T cells—specialized immune cells—seeking and destroying cancer cells around the clock can be exhausting. If scientists can understand why killer T cells become exhausted, then they …
LA JOLLA—Pancreatic cancers are among the most aggressive, deadly tumor types and, for years, researchers have struggled to develop effective drugs against the tumors. Now, Salk researchers have identified a …
LA JOLLA—Salk Institute physician-scientist Jesse Dixon has been named a Rita Allen Foundation Award Scholar, a distinction given to biomedical scientists whose research holds exceptional promise for revealing new pathways …
LA JOLLA—Glioblastoma, the most common and deadly form of brain cancer, grows rapidly to invade and destroy healthy brain tissue. The tumor sends out cancerous tendrils into the brain that …
LA JOLLA—The Salk Institute welcomes Assistant Professor Agnieszka Kendrick, a structural biologist who studies how cells recognize and transport cargo within the cell.
“Aga is an innovative scientist already making waves …
LA JOLLA—The immune system protects the body from invaders, such as bacteria, viruses, or tumors, with its intricate network of proteins, cells, and organs. Specialized immune cells, called cytotoxic T …
LA JOLLA—The Salk Institute and Autobahn Labs, an early-stage drug discovery incubator, will work together to identify and advance promising initial scientific discoveries through the preliminary steps of drug discovery …
LA JOLLA—Five Salk Institute faculty members have been promoted for their notable, innovative contributions to science. These faculty members have demonstrated leadership in their disciplines, pushing the boundaries of basic …
LA JOLLA—Salk Institute Professor Susan Kaech, director of the NOMIS Center for Immunobiology and Microbial Pathogenesis, has been elected to the American Academy of Arts and Sciences. She shares the …
LA JOLLA—Scientists often act as detectives, piecing together clues that alone may seem meaningless but together crack the case. Professor Reuben Shaw has spent nearly two decades piecing together such …
LA JOLLA—Cancer treatments have long been moving toward personalization—finding the right drugs that work for a patient’s unique tumor, based on specific genetic and molecular patterns. Many of these targeted …
LA JOLLA—Salk Professor Christian Metallo has been recognized for his outstanding contributions to advancing science by being named the next holder of the Daniel and Martina Lewis Chair, effective January …
LA JOLLA—As we age, …
SEMINAR: Cancer Center Trainee Research Seminar
WHEN: Wednesday, September 20, 2023 at 9:30 a.m.
SPEAKER: Shira Yomtoubian, PhD (Shaw Lab)
TALK TITLE: Deciphering the role of AMPK in Pancreatic Cancer
SPEAKER:Queralt Vallmajo Martin, PhD (Wahl Lab)
TALK TITLE: The molecular landscape of injury-induced mammary epithelial cell fate switching
HOST: Geoff Wahl, Reuben Shaw
LOCATION: Conrad T. Prebys Auditorium
2023 Padres Pedal the Cause
Padres Pedal the Cause is Curebound’s largest signature event, bringing together thousands of participants each year to raise money for collaborative cancer research. Hosted in partnership with the Padres, “Pedal” is San Diego’s most impactful fundraising experience with over $18 million raised to date to fund 80+ innovative research grants in all types of cancer. This year’s event raised $3,253,032 .
A World Without Cancer »
Cancer Research Pilot Grant Portfolio »
The Salk Institute and Indivumed partner to advance global cancer research »
Your partnership allows our scientists to accelerate the pace of high-risk, high-reward discoveries that have the potential to benefit the health of all humanity-be it cancer, Alzheimer’s disease, climate change, infectious diseases or more.
